Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001213900-25-121173·CureVac N.V.
Schedule 13D ownership disclosure
CUREVAC N V
Common Shares, par value (euro)0.12 per share · CUSIP: N2451R105
Event date: 2025-12-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- dievini Hopp BioTech holding GmbH & Co. KGReported CIK 0001696029
Shares: 0.00 · Class: 0.00%
- DH-LT-Investments GmbH
Shares: 0.00 · Class: 0.00%
- DH-Capital GmbH & Co. KG
Shares: 0.00 · Class: 0.00%
- OH Beteiligungen GmbH & Co. KG
Shares: 0.00 · Class: 0.00%
- Dietmar Hopp
Shares: 0.00 · Class: 0.00%
- Oliver Hopp
Shares: 0.00 · Class: 0.00%
- Daniel Hopp
Shares: 0.00 · Class: 0.00%
- DHFS II Holding GmbH & Co. KG
Shares: 0.00 · Class: 0.00%
- Zweite DH Verwaltungs GmbH
Shares: 0.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-121173
- Form type
- SCHEDULE 13D/A
- Filer
- CureVac N.V.
- CIK
- CIK 1809122
- Filed
- Dec 12, 2025
- Reporting period
- Dec 10, 2025
- Description
- Schedule 13D beneficial ownership